-
公开(公告)号：US11781121B2
公开(公告)日：2023-10-10
申请号：US17541565
申请日：2021-12-03
Applicant: DSM IP ASSETS B.V.
CPC classification number: C12N9/1085 , C12N9/0073 , C12N9/88 , C12N15/52 , C12P7/42 , C12P15/00 , C12P19/56 , C12Y114/13078 , C12Y205/01001 , C12Y402/03019
Abstract: The present invention relates a variant polypeptide having geranylgeranyl pyrophosphate synthase activity, which variant polypeptide comprises an amino acid sequence which, when aligned with a geranylgeranyl pyrophosphate synthase comprising the sequence set out in SEQ ID NO: 1, comprises at least one substitution of an amino acid residue corresponding to any of amino acids at positions 92, 100 or 235 said positions being defined with reference to SEQ ID NO: 1 and wherein the variant has one or more modified properties as compared with a reference polypeptide having geranylgeranyl pyrophosphate synthase activity. A variant polypeptide of the invention may be used in a recombinant host for the production of steviol or a steviol glycoside.
-
公开(公告)号：US11459548B2
公开(公告)日：2022-10-04
申请号：US17159962
申请日：2021-01-27
Applicant: DSM IP ASSETS B.V.
Inventor： Viktor Marius Boer , Johannes Gustaaf Ernst Van Leeuwen , Priscilla Zwartjens , Catharina Petronella Antonia Maria Kolen
IPC: C12N1/14 , C12N1/16 , C12N1/20 , C12N15/52 , C12N15/63 , C12P5/00 , C12P19/56 , C12N9/10 , A23L27/30 , A23L2/60
Abstract: The present invention relates to a recombinant host comprising a recombinant nucleic acid sequence encoding a polypeptide having at least about: a. 85% identity to the amino acid sequence set forth in SEQ ID NO: 1; b. 85% identity to the amino acid sequence set forth in SEQ ID NO: 3; c. 85% identity to the amino acid sequence set forth in SEQ ID NO: 6; d. 85% identity to the amino acid sequence set forth in SEQ ID NO: 9; e. 85% identity to the amino acid sequence set forth in SEQ ID NO: 11; f. 85% identity to the amino acid sequence set forth in SEQ ID NO: 14; g. 85% identity to the amino acid sequence set forth in SEQ ID NO: 17; h. 85% identity to the amino acid sequence set forth in SEQ ID NO: 20; i. 85% identity to the amino acid sequence set forth in SEQ ID NO: 22; or j. 85% identity to the amino acid sequence set forth in SEQ ID NO: 25.
-
公开(公告)号：US10808235B2
公开(公告)日：2020-10-20
申请号：US15781857
申请日：2016-12-08
Applicant: DSM IP ASSETS B.V.
Inventor： Johannes Gustaaf Ernst Van Leeuwen
Abstract: The application relates to a polypeptide having beta-glucosidase activity, its method of production and its uses.
-
公开(公告)号：US11913034B2
公开(公告)日：2024-02-27
申请号：US17381479
申请日：2021-07-21
Applicant: DSM IP ASSETS B.V.
CPC classification number: C12N9/0073 , A23L27/36 , C12P19/12 , C12Y114/13079 , A23V2002/00
Abstract: The present invention relates a polypeptide having kaurenoic acid 13-hydroxylase activity, which polypeptide comprises an amino acid sequence which, when aligned with a kaurenoic acid 13-hydroxylase comprising the sequence set out in SEQ ID NO: 1 or SEQ ID NO: 3, comprises at least one substitution of an amino acid corresponding to any of amino acids at positions 136, 248, 336 or 403, said positions being defined with reference to SEQ ID NO: 1 or SEQ ID NO: 3 and wherein the polypeptide has one or more modified properties as compared with a reference polypeptide having kaurenoic acid 13-hydroxylase activity. A polypeptide of the invention may be used in a recombinant host for the production of steviol or a steviol glycoside.
-
公开(公告)号：US10760085B2
公开(公告)日：2020-09-01
申请号：US15765549
申请日：2016-10-05
Applicant: DSM IP ASSETS B.V.
Abstract: The present invention relates a variant polypeptide having kaurenoic acid 13-hydroxylase activity, which variant polypeptide comprises an amino acid sequence which, when aligned with a kaurenoic acid 13-hydroxylase comprising the sequence set out in SEQ ID NO: 1, comprises at least one substitution of an amino acid residue corresponding to any of amino acids 72, 85, 108, 127, 129, 141, 172, 195, 196, 197, 199, 226, 236, 291, 302, 361 or 464, said positions being defined with reference to SEQ ID NO: 1 and wherein the variant has one or more modified properties as compared with a reference polypeptide having kaurenoic acid 13-hydroxylase activity. A variant polypeptide of the invention may be used in a recombinant host for the production of steviol or a steviol glycoside.
-
Patent Agency Ranking
公开(公告)号：US10316306B2
公开(公告)日：2019-06-11
申请号：US15501149
申请日：2015-08-06
Applicant: DSM IP ASSETS B.V.
Abstract: The present invention relates to an alpha amylase enzyme and to its use in the food, feed and non-food industry.
-
公开(公告)号：US12091436B2
公开(公告)日：2024-09-17
申请号：US18167119
申请日：2023-02-10
Applicant: DSM IP ASSETS B.V.
Inventor： Johannes Gustaaf Ernst Van Leeuwen , Viktor Marius Boer , Priscilla Zwartjens , Jos Van Vugt , René Marcel De Jong
CPC classification number: C07K14/39 , C12N9/0042 , C12P19/56 , C12Y106/02004
Abstract: The disclosure provides a recombinant cell capable of producing a steviol glycoside, wherein the cell comprises a nucleic acid coding for a variant of a parent polypeptide, wherein the variant has steviol glycoside transport mediating activity, wherein the variant comprises an amino acid sequence which, when aligned with the amino acid sequence of the parent polypeptide, comprises at least one modification of the amino acid residue corresponding to any of the amino acids in the amino acid sequence of the parent polypeptide, wherein the variant has an improved ability to produce rebaudioside M and optionally other steviol glycosides extracellularly if compared with the parent polypeptide when measured under the same conditions.
-
公开(公告)号：US11639497B2
公开(公告)日：2023-05-02
申请号：US16624072
申请日：2018-06-26
Applicant: DSM IP ASSETS B.V.
Inventor： Viktor Marius Boer , Johannes Gustaaf Ernst Van Leeuwen
Abstract: The present disclosure relates a polypeptide having UGT activity, which polypeptide comprises an amino acid sequence which, when aligned with a polypeptide having UGT activity comprising the sequence set out in SEQ ID NO: 2, comprises at least one substitution of an amino acid corresponding to any of amino acids at positions 35, 189, 280, 284, 285, 334 or 373, said positions being defined with reference to SEQ ID NO: 2 and wherein the polypeptide has one or more modified properties as compared with a reference polypeptide having UGT activity. A polypeptide according to the disclosure may be used in a recombinant cell for the production of steviol or a steviol glycoside.
-
公开(公告)号：US11104886B2
公开(公告)日：2021-08-31
申请号：US16467087
申请日：2017-12-04
Applicant: DSM IP Assets B.V.
Abstract: The present invention relates a polypeptide having kaurenoic acid 13-hydroxylase activity, which polypeptide comprises an amino acid sequence which, when aligned with a kaurenoic acid 13-hydroxylase comprising the sequence set out in SEQ ID NO: 1 or SEQ ID NO: 3, comprises at least one substitution of an amino acid corresponding to any of amino acids at positions 136, 248, 336 or 403, said positions being defined with reference to SEQ ID NO: 1 or SEQ ID NO: 3 and wherein the polypeptide has one or more modified properties as compared with a reference polypeptide having kaurenoic acid 13-hydroxylase activity. A polypeptide of the invention may be used in a recombinant host for the production of steviol or a steviol glycoside.
-
公开(公告)号：US11608364B2
公开(公告)日：2023-03-21
申请号：US17051299
申请日：2019-04-29
Applicant: DSM IP ASSETS B.V.
Inventor： Johannes Gustaaf Ernst Van Leeuwen , Viktor Marius Boer , Priscilla Zwartjens , Jos Van Vugt , René Marcel De Jong
Abstract: The disclosure provides a recombinant cell capable of producing a steviol glycoside, wherein the cell comprises a nucleic acid coding for a variant of a parent polypeptide, wherein the variant has steviol glycoside transport mediating activity, wherein the variant comprises an amino acid sequence which, when aligned with the amino acid sequence of the parent polypeptide, comprises at least one modification of the amino acid residue corresponding to any of the amino acids in the amino acid sequence of the parent polypeptide, wherein the variant has an improved ability to produce rebaudioside M and optionally other steviol glycosides extracellularly if compared with the parent polypeptide when measured under the same conditions.
-
-
-
-
-
-
-
-
-
Search Results
14
records
(took 0.016 seconds)
